Link to this page
PMO Precision Medicine Ontology
Last uploaded:
December 16, 2020
Jump to:
| Preferred Name | Esmolol | |
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00025521 |
|
| Database_Cross_Reference |
NCI_FDA:MDY902UXSR SNOMEDCT_US:372847006 MSH:C036604 RCD:x01C3 VANDF:4019746 CHV:0000016266 ATC:C07AB09 SNOMEDCT_US:77856005 NDDF:004745 NDFRT:N0000007249 NDFRT:N0000147837 NCI:C72617 MEDCIN:340407 MMSL:d00224 DRUGBANK:DB00187 MTHSPL:MDY902UXSR SNMI:C-803E0 RXNORM:49737
|
|
| label |
Esmolol
|
|
| MCID |
MC00050124
|
|
| PMOID |
PMO:00025521
|
|
| prefixIRI |
pmo:PMO_00025521
|
|
| prefLabel |
Esmolol
|
|
| Synonym |
Brevibloc Liq IV 250mg/ml Esmolol (product) Esmolol (substance) ESMOLOL Brevibloc Injection 10mg/ml methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate Brevibloc Liq IV 10mg/ml Brevibloc Injection 250mg/ml (±)-esmolol esmolol (±)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate Brevibloc Premixed Injection esmolol [Chemical/Ingredient] 3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester beta blockers esmolol esmolol (medication)
|
|
| Tree Number |
T6.4.7.3.4.6.2.1 T6.4.13.1.4.6.2.1 T6.4.1.6.2.1
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping